tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
:2196
Hong Kong Market

Shanghai Fosun Pharmaceutical (Group) Co (2196) Financial Statements

Compare
2 Followers

Shanghai Fosun Pharmaceutical (Group) Co Financial Overview

Shanghai Fosun Pharmaceutical (Group) Co's market cap is currently $67.22B. The company's EPS TTM is HK$0.3145441993; its P/E ratio is 14.23; and it has a dividend yield of 1.96%. Shanghai Fosun Pharmaceutical (Group) Co is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is HK$0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 41.07B¥ 41.40B¥ 43.95B¥ 39.01B¥ 30.31B
Gross Profit¥ 19.70B¥ 19.68B¥ 20.78B¥ 18.78B¥ 16.88B
Operating Income¥ 4.25B¥ 3.31B¥ 8.30B¥ 6.31B¥ 4.72B
EBITDA¥ 8.60B¥ 7.55B¥ 7.87B¥ 8.70B¥ 6.89B
Net Income¥ 2.77B¥ 2.39B¥ 3.73B¥ 4.73B¥ 3.66B
Balance Sheet
Cash & Short-Term Investments¥ 16.12B¥ 15.58B¥ 17.17B¥ 14.55B¥ 11.93B
Total Assets¥ 117.46B¥ 113.47B¥ 107.16B¥ 93.29B¥ 83.69B
Total Debt¥ 31.70B¥ 30.28B¥ 30.25B¥ 24.25B¥ 24.01B
Net Debt¥ 18.17B¥ 16.59B¥ 14.01B¥ 13.94B¥ 14.05B
Total Liabilities¥ 57.53B¥ 56.85B¥ 53.05B¥ 44.92B¥ 37.70B
Stockholders' Equity¥ 47.26B¥ 45.68B¥ 44.58B¥ 39.19B¥ 37.00B
Cash Flow
Free Cash Flow¥ 66.79M----
Operating Cash Flow¥ 4.48B¥ 3.41B¥ 4.22B¥ 3.95B¥ 2.58B
Investing Cash Flow-¥ -3.82B---
Financing Cash Flow--¥ 4.43B-¥ 1.47B
Currency in CNY

Shanghai Fosun Pharmaceutical (Group) Co Earnings and Revenue History

Shanghai Fosun Pharmaceutical (Group) Co Debt to Assets

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow

Shanghai Fosun Pharmaceutical (Group) Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis